This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for a new led for the eversense sensor’s optical system.
Device | Eversense Continuous Glucose Monitoring System |
Classification Name | Continuous Glucose Monitor, Implanted, Adjunctive Use |
Generic Name | Continuous Glucose Monitor, Implanted, Adjunctive Use |
Applicant | SENSEONICS, INCORPORATED |
Date Received | 2018-09-11 |
Decision Date | 2018-12-07 |
PMA | P160048 |
Supplement | S005 |
Product Code | QCD |
Advisory Committee | Clinical Chemistry |
Supplement Type | Real-time Process |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | SENSEONICS, INCORPORATED 20451 Seneca Meadows Parkway germantown, MD 20876-7005 |
Supplement Number | Date | Supplement Type |
---|---|---|
P160048 | Original Filing | |
S017 | 2020-11-12 | 30-day Notice |
S016 | ||
S015 | ||
S014 | 2019-08-27 | Normal 180 Day Track No User Fee |
S013 | 2019-07-31 | 30-day Notice |
S012 | ||
S011 | 2019-06-27 | Normal 180 Day Track |
S010 | 2019-06-24 | 30-day Notice |
S009 | 2019-05-28 | 30-day Notice |
S008 | 2018-12-11 | Real-time Process |
S007 | 2018-11-28 | Normal 180 Day Track No User Fee |
S006 | ||
S005 | 2018-09-11 | Real-time Process |
S004 | 2018-09-07 | Real-time Process |
S003 | 2018-08-27 | Normal 180 Day Track No User Fee |
S002 | 2018-08-07 | Normal 180 Day Track |
S001 | 2018-07-20 | Normal 180 Day Track No User Fee |